Delivery Order SPE2DB22D2007-SPE2DB25FJ4WB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in a 30-gram quantity, valued at $20,510.86. This delivery order, issued on September 11, 2025, represents a firm fixed-price contract with an ultimate completion date of September 12, 2025. The contract carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,887.66 to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 30-gram units. This firm fixed price, non-competitive delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The pharmaceutical product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 2, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram units, with a ceiling value of $1,484.50. This firm fixed-price delivery order, with an ultimate completion date of July 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation....
- The Defense Logistics Agency awarded a $1,002.95 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram units. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery...
- This is a $1,139.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 100 gram tubes of Pimecrolimus 1% cream. The contract has an ultimate completion date of July 3, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in a 60-gram container, valued at $1,075.73 with a firm fixed price contract type. The delivery order, issued on June 13, 2025, is scheduled for ultimate completion by June 16, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded transaction through the federal procurement...
- This is a $8,995.16 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pimecrolimus 1% cream. The contract has an ultimate completion date of July 15, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Pimecrolimus 1% Cream in 100-gram units. This contract, valued at $3,265.16, represents a firm fixed-price delivery order with an ultimate completion date of August 11, 2025. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,963.14 firm fixed price contract is for the supply of Pimecrolimus 1% Cream in 100g containers. There is no set-aside designation for this order, which has an ultimate completion date of August 21, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,335.82, is for the supply of Pimecrolimus 1% Cream, a prescription topical medication. The contract is a Firm Fixed Price delivery order and is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4WBDelivery Order
The Defense Logistics Agency (DLA) awarded a $2,458.75 delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in 100-gram units, with an ultimate completion date of September 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and active through December 2026. The prime IDV serves as a global pharmaceutical support vehicle enabling the contractor to supply a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The contract supports multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen Drug Corp as a key provider in the DLA's pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/11/25 |